These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7866337)

  • 1. Plasma protein C and antithrombin III in patients with acute leukemia.
    Cucuianu A; Brudaşcă I; Colhon D; Paţiu M; Basarab C; Cucuianu M
    Rom J Intern Med; 1994; 32(3):209-14. PubMed ID: 7866337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies on plasma protein C. Correlation with serum cholinesterase.
    Cucuianu M; Brudasca I; Trif I; Stancu A
    Nouv Rev Fr Hematol (1978); 1993; 35(5):481-6. PubMed ID: 8295822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cholesterol and apoprotein B levels and serum cholinesterase activity in selected hematologic malignancies.
    Cucuianu A; Malide D; Petrov L; Patiu M; Vlaicu S; Cucuianu M
    Rom J Intern Med; 1992; 30(4):261-8. PubMed ID: 1299417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and antigenic antithrombin III in angina pectoris and acute myocardial infarction patients.
    Vonica A; Văgăonescu T; Cristea A; Stăncioiu N
    Med Interne; 1990; 28(4):311-7. PubMed ID: 2100876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma factor VIII:c activity in patients with unstable angina pectoris.
    Olinic D; Brudaşcă I; Colhon D; Stoia M; Cucuianu M
    Rom J Intern Med; 1996; 34(1-2):65-71. PubMed ID: 8908632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation inhibitors in patients with neoplasms].
    Páramo JA; Cuesta B; Hernández M; Fernández J; Paloma MJ; Rifón J; Rocha E
    Med Clin (Barc); 1989 Feb; 92(5):164-6. PubMed ID: 2524631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C and antithrombin III in children with acute leukemia.
    Atlihan F; Karakaş Z; Batun S
    Turk J Pediatr; 1993; 35(1):45-51. PubMed ID: 8236517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily modifications of plasma fibrinogen platelets aggregation, Howell's time, PTT, TT, and antithrombin II in normal subjects and in patients with vascular disease.
    Petralito A; Mangiafico RA; Gibiino S; Cuffari MA; Miano MF; Fiore CE
    Chronobiologia; 1982; 9(2):195-201. PubMed ID: 7117042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
    Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III control in patients with long-term anticoagulant therapy].
    Hönig JF; Merten HA; Korth O; Halling F; Köstering H
    Dtsch Z Mund Kiefer Gesichtschir; 1991; 15(5):330-3. PubMed ID: 1840095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of coagulation parameters in the early period after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in natural anticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
    Leblond V; Salehian BD; Borel C; Mapakou CP; Dombret H; Sutton L; Binet JL; Ankri A
    Bone Marrow Transplant; 1993 Apr; 11(4):299-305. PubMed ID: 8485478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in coagulation inhibitors (AT III, protein C, protein S) in patients with liver cirrhosis].
    Kobayashi I; Kurihara A; Hamaoka S; Amemiya N; Endo T; Okuyama K
    Rinsho Byori; 1989 Apr; Spec No 81():93-7. PubMed ID: 2526888
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma protein S-antigen (PS:Ag) in selected disease states.
    Brudaşca I; Cucuianu M; Stancu A; Colhon DM
    Rom J Intern Med; 1994; 32(1):29-35. PubMed ID: 8081308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.